Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AB Science

AB Science
2001 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
AB STOCK SYMBOL
$5.30 SHARE PRICE (As of Friday Closing)
Description

Developer of novel targeted pharmaceutical products intended to offer research, development and commercialization of protein kinase inhibitors (PKIs). The company's novel targeted pharmaceutical products are focused in meeting unmet medical needs, using tyrosine kinase inhibitors enabling patients avail integrated pharmaceuticals for the treatment in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders.

Ownership Status
Publicly Held
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PAR
Primary Office
  • 3, Avenue George V
  • 75008 Paris
  • France

+33 01 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AB Science’s full profile, request a free trial.

AB Science Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.94 - $12.98 $224M $5.47 -$0.85 172K 41M

AB Science Financials Summary

In Thousands,
USD
TTM
31-Dec-2017
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 378,339 378,339 519,611 468,530
Revenue 1,961 1,961 1,668 2,534
EBITDA (30,218) (30,218) (29,086) (28,452)
Net Income (30,587) (30,587) (30,636) (29,637)
Total Assets 60,705 60,705 39,975 35,618
Total Debt 11,194 11,194 9,813 24,190
Public Fundamental Data provided by Morningstar, Inc. disclaimer

AB Science Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore AB Science‘s full profile, request access.

Request full access to PitchBook

AB Science Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore AB Science‘s full profile, request access.

Request full access to PitchBook

AB Science Executive Team (3)

Name Title Board
Seat
Contact
Info
Laurent Guy Chief Financial Officer
Alain Moussy Co-Founder, Chief Executive Officer, President & Chairman

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »

AB Science Board Members (2)

Name Representing Role Since Contact
Info
Alain Moussy AB Science Co-Founder, Chief Executive Officer, President & Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »